Cardinal Health Inc (NYSE:CAH) – Stock analysts at William Blair boosted their Q3 2018 earnings per share (EPS) estimates for shares of Cardinal Health in a research report issued on Thursday. William Blair analyst J. Kreger now forecasts that the company will post earnings of $1.78 per share for the quarter, up from their previous forecast of $1.52. William Blair also issued estimates for Cardinal Health’s Q4 2018 earnings at $1.48 EPS, FY2018 earnings at $5.46 EPS, Q1 2019 earnings at $1.40 EPS, Q2 2019 earnings at $1.69 EPS, Q3 2019 earnings at $1.78 EPS, Q4 2019 earnings at $1.64 EPS, FY2019 earnings at $6.51 EPS, FY2020 earnings at $7.18 EPS and FY2021 earnings at $7.79 EPS.

Cardinal Health (NYSE:CAH) last announced its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.09. The company had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. Cardinal Health’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.24 earnings per share.

A number of other equities research analysts have also recently issued reports on CAH. Evercore ISI began coverage on shares of Cardinal Health in a research report on Thursday, January 4th. They issued an “in-line” rating and a $67.00 target price for the company. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a research note on Thursday, October 12th. Jefferies Group dropped their price target on Cardinal Health from $77.00 to $67.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. Finally, Robert W. Baird reaffirmed a “hold” rating and issued a $73.00 price target on shares of Cardinal Health in a research note on Sunday, September 17th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the stock. Cardinal Health presently has a consensus rating of “Hold” and an average target price of $72.99.

Shares of Cardinal Health (CAH) opened at $71.49 on Monday. The stock has a market cap of $22,491.01, a PE ratio of 20.78, a PEG ratio of 2.03 and a beta of 0.85. Cardinal Health has a 52-week low of $54.66 and a 52-week high of $84.88. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be paid a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Friday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 53.78%.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its stake in Cardinal Health by 1.9% during the second quarter. Vanguard Group Inc. now owns 23,642,277 shares of the company’s stock worth $1,842,205,000 after acquiring an additional 440,967 shares in the last quarter. Macquarie Group Ltd. raised its stake in Cardinal Health by 4.6% during the third quarter. Macquarie Group Ltd. now owns 10,105,374 shares of the company’s stock worth $676,253,000 after acquiring an additional 445,399 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Cardinal Health by 38.6% during the third quarter. Ameriprise Financial Inc. now owns 4,930,457 shares of the company’s stock worth $329,964,000 after acquiring an additional 1,373,334 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Cardinal Health by 10.8% during the third quarter. Bank of New York Mellon Corp now owns 3,846,209 shares of the company’s stock worth $257,388,000 after acquiring an additional 375,742 shares in the last quarter. Finally, American Century Companies Inc. raised its stake in Cardinal Health by 58.7% during the third quarter. American Century Companies Inc. now owns 2,976,776 shares of the company’s stock worth $199,206,000 after acquiring an additional 1,100,507 shares in the last quarter. 88.36% of the stock is owned by hedge funds and other institutional investors.

WARNING: This report was reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2018/01/15/cardinal-health-inc-expected-to-earn-q3-2018-earnings-of-1-78-per-share-cah.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.